Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Published Date: 21 Oct 2025

Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Two-part prodrug system activates immune attack only in tumor's unique environment

2.

Never in a million years did I think I'd have to limit my chemotherapy.

3.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

4.

New drug combination shows particularly good results in patients with HPV-negative head and neck cancer

5.

Un nou sistem de endoscopică imaging are capacitatea de a detecta mai mulți fluorescent tracers.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot